rspНаучно-практическая ревматологияRheumatology Science and Practice1995-44841995-4492IMA-PRESS, LLC10.14412/1995-4484-2015-456-459rsp-2119Research ArticleНАБЛЮДЕНИЯ ИЗ ПРАКТИКИCLINICAL NOTESСлучай вызванной лефлуномидом клинико-морфологической регрессии АА-амилоидоза и ремиссии болезни Стилла взрослыхCASE OF LEFLUNOMIDE-INDUCED CLINICAL AND MORPHOLOGICAL REGRESSION OF AA-AMYLOIDOSIS AND REMISSION OF ADULT-ONSET STILL'S DISEASEМуравьевЮ. В.MuravyevYu. V.murawyu@mail.ruАлексееваА. В.AlekseevaA. V.Раденска-ЛоповокС. Г.Radenska-LopovokS. G.ЛебедеваВ. В.LebedevaV. V.ФГБНУ Научно- исследовательский институт ревматологии им. В.А. Насоновой, Москва, Россия 115522 Москва, Каширское шоссе, 34АРоссияV.A. Nasonova Research Institute of Rheumatology, Moscow, Russia 34A, Kashirskoe Shosse, Moscow 115522Russian Federation201510092015534456459Copyright © Муравьев Ю.В., Алексеева А.В., Раденска-Лоповок С.Г., Лебедева В.В., 20152015Муравьев Ю.В., Алексеева А.В., Раденска-Лоповок С.Г., Лебедева В.В.Muravyev Y.V., Alekseeva A.V., Radenska-Lopovok S.G., Lebedeva V.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://rsp.mediar-press.net/rsp/article/view/2119

Описано многолетнее наблюдение, с обсуждением возможного механизма, индуцированной лефлуномидом клинико-морфологической регрессии АА-амилоидоза, диагностированного на нефротической стадии, при болезни Стилла, развившейся у взрослых.

The paper describes a long-term observation and discusses the possible mechanism of leflunomide-induced clinical and morphological regression of AA-amyloidosis diagnosed at a nephrotic stage in the presence of adult-onset Still's disease.

АА-амилоидозболезнь Стилларазвившаяся у взрослыхлефлуномидремиссиясывороточный амилоид A.AA-amyloidosisadult-onset Still’s diseaseleflunomideremissionserum amyloid A.ReferencesМуравьев ЮВ, Алексеева АВ, Раденска-Лоповок СГ. АА-амилоидоз при болезни Стилла, развившейся у взрослых. Научно-практическая ревматолог Still’s disease, develop in adults. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2011;(3):95–8 (In Russ.)].Муравьев ЮВ, Алексеева АВ, Раденска-Лоповок СГ. АА-амилоидоз при болезни Стилла, развившейся у взрослых. Научно-практическая ревматолог Still’s disease, develop in adults. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2011;(3):95–8 (In Russ.)].Harington TM, Moran JJ, Davis DE. Amyloidosis in adult onset Still's disease. J Rheumatol. 1981;8(5):833–6.Harington TM, Moran JJ, Davis DE. Amyloidosis in adult onset Still's disease. J Rheumatol. 1981;8(5):833–6.Elkon KB, Hughes GRV, Bywaters EGL, et al. Adult onset Still's disease. Twenty-year follow up and further studies ofpatients with active disease. Arthritis Rheum. 1982;25(6):647–54. doi: 10.1002/art.1780250607Elkon KB, Hughes GRV, Bywaters EGL, et al. Adult onset Still's disease. Twenty-year follow up and further studies ofpatients with active disease. Arthritis Rheum. 1982;25(6):647–54. doi: 10.1002/art.1780250607Vigneron AM, Kaplan G, Labrousse C, et al. Amylose au cours de la maladie de Still de l'adulte. Arthritis Rheum. 1982;25(6):647–54.Vigneron AM, Kaplan G, Labrousse C, et al. Amylose au cours de la maladie de Still de l'adulte. Arthritis Rheum. 1982;25(6):647–54.Cush JJ, Medsger TA, Christy WC, et al. Adult onset Still's disease. Clinical course and outcome. Arthritis Rheum. 1987;30(2):186–94. doi: 10.1002/art.1780300209Cush JJ, Medsger TA, Christy WC, et al. Adult onset Still's disease. Clinical course and outcome. Arthritis Rheum. 1987;30(2):186–94. doi: 10.1002/art.1780300209Reginato AJ, Shumacher HR, Baker D, et al. Adult onset Still's disease: Experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum. 1987;17(1):39–57. doi: 10.1016/0049-0172(87)90015-1Reginato AJ, Shumacher HR, Baker D, et al. Adult onset Still's disease: Experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum. 1987;17(1):39–57. doi: 10.1016/0049-0172(87)90015-1Wendling D, Philippe GH, Billerey C, et al. Adult onset Still's disease and related renal amyloidosis. Ann Rheum Dis. 1991;50(4):257–9. doi: 10.1136/ard.50.4.257Wendling D, Philippe GH, Billerey C, et al. Adult onset Still's disease and related renal amyloidosis. Ann Rheum Dis. 1991;50(4):257–9. doi: 10.1136/ard.50.4.257Bamberym P, Kaur U, Bhusnurmath SR, et al. Adult onset Still's disease in north India. Rheumatol Int. 1987;7(4):173–6. doi: 10.1007/BF00270366Bamberym P, Kaur U, Bhusnurmath SR, et al. Adult onset Still's disease in north India. Rheumatol Int. 1987;7(4):173–6. doi: 10.1007/BF00270366Cabane J, Michon A, Ziza JM, et al. Comparison of long term evolution of adult onset and juvenile onset Still's disease, both followed up for more than 10 years. Ann Rheum Dis. 1990;49(5):283. doi: 10.1136/ard.49.5.283Cabane J, Michon A, Ziza JM, et al. Comparison of long term evolution of adult onset and juvenile onset Still's disease, both followed up for more than 10 years. Ann Rheum Dis. 1990;49(5):283. doi: 10.1136/ard.49.5.283Migita K, Miyashita T, Maeda Y, et al. An active metabolite of leflunomide, A77 1726, inhibits the production of serum amyloid A protein in human hepatocytes. Rheumatology (Oxford). 2005;44(4):443–8. doi: 10.1093/rheumatology/keh462Migita K, Miyashita T, Maeda Y, et al. An active metabolite of leflunomide, A77 1726, inhibits the production of serum amyloid A protein in human hepatocytes. Rheumatology (Oxford). 2005;44(4):443–8. doi: 10.1093/rheumatology/keh462Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356(23):2361–71. doi: 10.1056/NEJMoa070265Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356(23):2361–71. doi: 10.1056/NEJMoa070265Kennedy WR. Renal amyloidosis. Can Med Assoc J. 1935;33(4):385–8.Kennedy WR. Renal amyloidosis. Can Med Assoc J. 1935;33(4):385–8.Trasoff A, Schneeberg N, Scarf M. Recovery from multiple rheumatoid arthritis complicated by amyloidosis in a child. Arch Intern Med. 1944;74:4. doi: 10.1001/archinte. 1944.00210190012002Trasoff A, Schneeberg N, Scarf M. Recovery from multiple rheumatoid arthritis complicated by amyloidosis in a child. Arch Intern Med. 1944;74:4. doi: 10.1001/archinte. 1944.00210190012002Parkins RA, Bywaters EG. Regression of amyloidosis secondary to rheumatoid arthritis. Br Med J. 1959;1(5121):536–40. doi: 10.1136/bmj.1.5121.536Parkins RA, Bywaters EG. Regression of amyloidosis secondary to rheumatoid arthritis. Br Med J. 1959;1(5121):536–40. doi: 10.1136/bmj.1.5121.536Komatsuda A, Morita K, Ohtani H, et al. Remission of the nephrotic syndrome in a patient with renal amyloidosis due to rheumatoid arthritis treated with prednisolone and methotrexate. Am J Kidney Dis. 1998 Nov;32(5):E7. doi: 10.1016/S0272-6386(98)70154-4Komatsuda A, Morita K, Ohtani H, et al. Remission of the nephrotic syndrome in a patient with renal amyloidosis due to rheumatoid arthritis treated with prednisolone and methotrexate. Am J Kidney Dis. 1998 Nov;32(5):E7. doi: 10.1016/S0272-6386(98)70154-4Shapiro DL, Spiera H. Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine. A case report. Arthritis Rheum. 1995 Dec;38(12):1851–4. doi:Shapiro DL, Spiera H. Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine. A case report. Arthritis Rheum. 1995 Dec;38(12):1851–4. doi:1002/art.17803812201002/art.1780381220Falck HM, Tö rnroth T, Skrifvars B, Wegelius O. Resolution of renal amyloidosis secondary to rheumatoid arthritis. Acta Med Scand. 1979;205(7):651–6. doi: 10.1111/j.0954-6820.1979.tb06121.xFalck HM, Tö rnroth T, Skrifvars B, Wegelius O. Resolution of renal amyloidosis secondary to rheumatoid arthritis. Acta Med Scand. 1979;205(7):651–6. doi: 10.1111/j.0954-6820.1979.tb06121.xTanaka F, Migita K, Honda S, et al. Clinical outcome and survival of secondary (AA) amyloidosis. Clin Exp Rheumatol. 2003;21:343-6.Tanaka F, Migita K, Honda S, et al. Clinical outcome and survival of secondary (AA) amyloidosis. Clin Exp Rheumatol. 2003;21:343-6.Okuda Y, Takasugi K, Oyama T, et al. Intractable diarrhea associated with secondary amyloidosis in rheumatoid arthritis. Ann Rheum Dis. 1997;56:535–41. doi: 10.1136/ard.56.9.535Okuda Y, Takasugi K, Oyama T, et al. Intractable diarrhea associated with secondary amyloidosis in rheumatoid arthritis. Ann Rheum Dis. 1997;56:535–41. doi: 10.1136/ard.56.9.535Kuroda T, Tanabe N, Harada T, et al. Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis. Clin Rheumatol. 2006;25:498–505. doi: 10.1007/s10067-005-0079-zKuroda T, Tanabe N, Harada T, et al. Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis. Clin Rheumatol. 2006;25:498–505. doi: 10.1007/s10067-005-0079-zНасонов ЕЛ. Внедрение высоких медицинских технологий в ревматологии: проблемы и решения. Научно-практическая ревматология. 2008;(2):4–5 [Nasonov EL. The introduction of advanced medical technology in rheumatology: Problems and Solutions. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2008;(2):4–5 (In Russ.)].Насонов ЕЛ. Внедрение высоких медицинских технологий в ревматологии: проблемы и решения. Научно-практическая ревматология. 2008;(2):4–5 [Nasonov EL. The introduction of advanced medical technology in rheumatology: Problems and Solutions. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2008;(2):4–5 (In Russ.)].Elkayam O, Hawkins PN, Lachmann H, et al. Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab. Arthritis Rheum. 2002;46:2571–3. doi: 10.1002/art.10581Elkayam O, Hawkins PN, Lachmann H, et al. Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab. Arthritis Rheum. 2002;46:2571–3. doi: 10.1002/art.10581Kuroda T, Tanabe N, Kobayashi D, et al. Treatment with biologic agents improves the prognosis of patients with rheumatoid arthritis and amyloidosis. J Rheumatol. 2012;39(7):1348–54. doi: 10.3899/jrheum.111453Kuroda T, Tanabe N, Kobayashi D, et al. Treatment with biologic agents improves the prognosis of patients with rheumatoid arthritis and amyloidosis. J Rheumatol. 2012;39(7):1348–54. doi: 10.3899/jrheum.111453

The authors declare that there are no conflicts of interest present.